DNA 製造市场：按 DNA 类型、应用、技术、等级、生产规模、最终用户和地区划分

DNA製造市场规模预计在2025年达到64.4亿美元，预计在2032年达到195.6亿美元，2025年至2032年的年复合成长率（CAGR）为17.2%。

全球DNA製造市场是生物技术产业中一个快速发展的领域，涵盖去氧核糖核酸(DNA) 的生产、合成和商业性生产，广泛应用于製药、科研、诊断和治疗领域。由于基因工程、合成生物学和个人化医疗领域的空前进步，该市场已成为现代生物经济的重要组成部分。 DNA製造涉及化学合成、酵素生产和生物製造技术等先进工艺，以创建高品质的DNA构建体、质体、寡核苷酸和合成基因。

该市场服务于各种各样的终端用户，从开发基因疗法和疫苗的製药公司到进行基础基因研究的学术研究机构。主要的製造流程包括固相合成、PCR扩增和基于发酵的生产系统，从而实现可扩展且经济高效的DNA生产。该行业在自动化、品管系统和纯化方法方面取得了重大创新，提高了生产效率和产品品质。随着全球焦点转向精准医疗、CRISPR-Cas9等基因编辑技术以及下一代疗法，DNA製造市场持续在多个治疗领域扩展其影响力，包括肿瘤学、罕见疾病和感染疾病，并已成为现代生物技术进步的重要支柱。

市场动态

全球DNA製造市场受到多种强大驱动力的推动，这些驱动力正在从根本上改变生物技术格局，并创造前所未有的成长机会。第一个驱动力是基因治疗开发的指数级增长，大量临床试验正在通过监管审批流程，并获得美国食品药物管理局（FDA）和欧洲药品管理局（EMA）等机构的核准，这带来了对高品质治疗性DNA产品的巨大需求。新冠疫情凸显了快速疫苗开发和生产能力的重要性，尤其是对于mRNA疫苗而言，其生产需要先进的DNA模板和质体，这显着加速了市场成长。公共和私营部门对合成生物学和基因工程研究的投资不断增加，推动了对客製化DNA合成服务和标准化DNA组件的需求。然而，该市场面临着许多限制因素，包括严格的法规结构，这些框架要求提供大量的文件、品管措施并遵守良好生产规范（GMP），这大大增加了生产成本和上市时间。建立最先进的生产设施所需的高额资本投入，以及对专业、熟练的人员和先进设备的需求，为新市场的进入设置了障碍。与维持DNA稳定性、确保纯度水平以及将生产流程从实验室规模扩展到商业规模相关的技术挑战仍然是业务限制因素。然而，DNA在DNA资料储存、农业生物技术和环境修復等新兴领域的不断扩展应用，为市场带来了庞大的商机。个人化医疗方法的日益普及，催生了对患者特异性DNA构建体和客製化生产服务的需求。自动化、人工智慧主导的品管以及新型合成方法等技术进步，正在开闢降低成本和提高效率的新途径，而全球遗传疾病的日益流行也持续扩大了基于DNA的治疗解决方案的潜在市场。

本次调查的主要特点

• 本报告对全球 DNA 製造市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
• 它还揭示了各个领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球 DNA 製造市场的主要企业。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴车型、市场扩张和行销策略做出明智的决策。
• 全球 DNA 製造市场报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过用于分析全球 DNA 製造市场的各种策略矩阵更轻鬆地做出决策。

目录

第 1 章：调查目标与先决条件

• 调查目的
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章：市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 抑制因素
• 机会
• 影响分析
• 主要进展
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 产业趋势

4. 2020-2032 年全球 DNA 製造市场（依 DNA 类型）

• 合成DNA
• 质体DNA
• 遗传DNA

5. 全球 DNA 製造市场（按应用划分），2020-2032 年

• 瘤
• 基因治疗
• 疫苗研发
• 免疫疗法
• 再生医学
• 神经退化性疾病
• 心血管疾病
• 感染疾病
• 其他（罕见遗传疾病）

6. 2020-2032 年全球 DNA 製造市场（依技术划分）

• PCR（聚合酵素链锁反应）
• CRISPR/Cas9
• 次世代定序（NGS）
• 基因合成
• 其他（基因编辑/改造）

7. 2020-2032 年全球 DNA 製造市场（依等级）

• GMP级（良好生产规范）
• 研发级（研究与发展）

8. 2020-2032 年全球 DNA 製造市场（依生产规模）

• 商业规模生产
• 客製化规模生产

9. 2020-2032 年全球 DNA 製造市场（依最终用户划分）

• 製药公司
• 生技公司
• 合约研究组织
• 其他（学术、研究机构等）

10. 2020-2032 年全球 DNA 製造市场（按地区）

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第十一章 竞争格局

• Lonza Group
  • WuXi AppTec
• GenScript Biotech
• Thermo Fisher Scientific
• Sigma-Aldrich（Merck Group）
• Integrated DNA Technologies
• Eurofins Genomics
• OriGene Technologies
• Bluebird Bio
• Sangamo Therapeutics
• Cellectis
• Caribou Biosciences
• Editas Medicine
• Intellia Therapeutics

第 12 章分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十三章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

DNA Manufacturing Market is estimated to be valued at USD 6.44 Bn in 2025 and is expected to reach USD 19.56 Bn by 2032, growing at a compound annual growth rate (CAGR) of 17.2% from 2025 to 2032.

The global DNA manufacturing market represents a rapidly evolving sector within the biotechnology industry, encompassing the production, synthesis, and commercial manufacturing of deoxyribonucleic acid (DNA) for various applications across pharmaceutical, research, diagnostic, and therapeutic domains. This market has emerged as a critical component of the modern bioeconomy, driven by unprecedented advances in genetic engineering, synthetic biology, and personalized medicine. DNA manufacturing involves sophisticated processes including chemical synthesis, enzymatic production, and bio-manufacturing techniques to create high-quality DNA constructs, plasmids, oligonucleotides, and synthetic genes.

The market serves diverse end users ranging from pharmaceutical companies developing gene therapies and vaccines to academic research institutions conducting fundamental genetic research. Key manufacturing processes include solid-phase synthesis, PCR amplification, and fermentation-based production systems that enable scalable and cost-effective DNA production. The industry has witnessed significant technological breakthroughs in automation, quality control systems, and purification methodologies, enhancing both production efficiency and product quality. As the global focus shifts toward precision medicine, gene editing technologies like CRISPR-Cas9, and next-generation therapeutics, the DNA manufacturing market continues to expand its footprint across multiple therapeutic areas including oncology, rare diseases, and infectious diseases, establishing itself as an indispensable pillar of modern biotechnological advancement.

Market Dynamics

The global DNA manufacturing market is propelled by several robust drivers that are fundamentally reshaping the biotechnology landscape and creating unprecedented growth opportunities. The primary driver stems from the exponential growth in gene therapy development, with numerous clinical trials advancing through regulatory pipelines and receiving approvals from agencies like the USFDA and EMA, creating substantial demand for high-quality therapeutic DNA products. The COVID-19 pandemic significantly accelerated market growth by highlighting the critical importance of rapid vaccine development and manufacturing capabilities, particularly for mRNA vaccines that require sophisticated DNA templates and plasmids for production. Rising investments in synthetic biology and genetic engineering research by both private and public sectors are driving demand for custom DNA synthesis services and standardized DNA components. However, the market faces notable restraints including stringent regulatory frameworks that require extensive documentation, quality control measures, and compliance with Good Manufacturing Practice (GMP) standards, which significantly increase production costs and time-to-market. The high capital investment required for establishing state-of-the-art manufacturing facilities, coupled with the need for specialized skilled personnel and advanced equipment, creates barriers for new market entrants. Technical challenges related to maintaining DNA stability, ensuring purity levels, and scaling production processes from laboratory to commercial scale continue to pose operational constraints. Nevertheless, the market presents substantial opportunities driven by the expanding applications of DNA in emerging fields such as DNA data storage, agricultural biotechnology, and environmental remediation. The growing adoption of personalized medicine approaches is creating demand for patient-specific DNA constructs and custom manufacturing services. Technological advancements in automation, artificial intelligence-driven quality control, and novel synthesis methods are opening new avenues for cost reduction and efficiency improvements, while the increasing prevalence of genetic disorders globally continues to expand the addressable market for DNA-based therapeutic solutions.

Key Features of the Study

• This report provides in-depth analysis of the global DNA manufacturing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global DNA manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Lonza Group, WuXi AppTec, GenScript Biotech, Thermo Fisher Scientific, Sigma-Aldrich (Merck Group), Integrated DNA Technologies, Eurofins Genomics, OriGene Technologies, Bluebird Bio, Sangamo Therapeutics, Cellectis, Caribou Biosciences, Editas Medicine, and Intellia Therapeutics.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global DNA manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global DNA manufacturing market.

Market Segmentation

• Type of DNA Insights (Revenue, USD Bn, 2020 - 2032)
  • Synthetic DNA
  • Oligonucleotide synthesis
  • Custom DNA synthesis
  • Plasmid DNA
  • Gene DNA
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Oncology
  • Gene Therapy
  • Vaccine Development
  • Immunotherapy
  • Regenerative Medicine
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Others (Rare Genetic Disorders)
• Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • PCR (Polymerase Chain Reaction)
  • CRISPR/Cas9
  • Next-Generation Sequencing (NGS)
  • Gene Synthesis
  • Others (Gene Editing and Modification)
• Grade Insights (Revenue, USD Bn, 2020 - 2032)
  • GMP Grade (Good Manufacturing Practice)
  • R and D Grade (Research and Development)
• Production Scale Insights (Revenue, USD Bn, 2020 - 2032)
  • Commercial Scale Production
  • Custom Scale Production
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations
  • Others (Academic and Research Institutions, etc.)
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Lonza Group
  • WuXi AppTec
  • GenScript Biotech
  • Thermo Fisher Scientific
  • Sigma-Aldrich (Merck Group)
  • Integrated DNA Technologies
  • Eurofins Genomics
  • OriGene Technologies
  • Bluebird Bio
  • Sangamo Therapeutics
  • Cellectis
  • Caribou Biosciences
  • Editas Medicine
  • Intellia Therapeutics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global DNA Manufacturing Market, By Type of DNA
  • Global DNA Manufacturing Market, By Application
  • Global DNA Manufacturing Market, By Technology
  • Global DNA Manufacturing Market, By Grade
  • Global DNA Manufacturing Market, By Production Scale
  • Global DNA Manufacturing Market, By End User
  • Global DNA Manufacturing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global DNA Manufacturing Market, By Type of DNA, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Synthetic DNA
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Oligonucleotide synthesis
    • Custom DNA synthesis
• Plasmid DNA
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gene DNA
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global DNA Manufacturing Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gene Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Vaccine Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immunotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Regenerative Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurodegenerative Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Rare Genetic Disorders)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global DNA Manufacturing Market, By Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• PCR (Polymerase Chain Reaction)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• CRISPR/Cas9
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Next-Generation Sequencing (NGS)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gene Synthesis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Gene Editing and Modification)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global DNA Manufacturing Market, By Grade, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• GMP Grade (Good Manufacturing Practice)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• R and D Grade (Research and Development)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global DNA Manufacturing Market, By Production Scale, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Commercial Scale Production
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Custom Scale Production
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global DNA Manufacturing Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Academic and Research Institutions, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global DNA Manufacturing Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type of DNA, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Production Scale, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type of DNA, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Production Scale, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type of DNA, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Production Scale, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type of DNA, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Production Scale, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type of DNA, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Production Scale, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type of DNA, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Production Scale, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Lonza Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
• Strategies
  • WuXi AppTec
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GenScript Biotech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sigma-Aldrich (Merck Group)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Integrated DNA Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Eurofins Genomics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• OriGene Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bluebird Bio
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sangamo Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cellectis
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Caribou Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Editas Medicine
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Intellia Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us